Tiantan Biological schedules Q3 2025 earnings briefing

Beijing Tiantan Biological Products Co., Ltd. (SSE:600161) will host its 2025 third-quarter earnings briefing on November 12, 2025, from 9:30 AM to 10:30 AM. The company's 2025 third-quarter report was released on October 25, 2025. The virtual event will be held on the Shanghai Stock Exchange Roadshow Center website, offering an interactive online format.

Key company representatives attending the briefing include Mr. He Yanlin, director and deputy general manager (in charge of daily operations); Ms. Fang Yan, independent director; and Mr. Wang Hongqing, chief financial officer and board secretary. Attendees may be subject to change.

Investors can submit questions in advance from November 5, 2025, until 4:00 PM on November 11, 2025, via the "Question Pre-collection" section on the SSE Roadshow Center website or by emailing ttswdb@sinopharm.com. The company will address common investor inquiries during the briefing. Following the event, a replay and key takeaways will be available on the SSE Roadshow Center website.